卫分证

wèi fèn zhèng
  • Wei phase syndrome
卫分证卫分证
卫分证[wèi fèn zhèng]
  1. 结果①卫分证IL1β、IL6水平升高(P<0.01或P<0.05);

    Secondly , the levels of IL 6 and IL 10 were significantly higher in Qifen pattern ( P < 0.01 ~ 0.05 ) than in Weifen pattern .

  2. 不同病位的卫分证间血浆VIP、TXB2水平均无明显差异(P>0.05)。

    As for the levels of VIP and TXB2 in weifen syndrome with different internal organs infected , there was no significant difference ( P > 0 . 05 ) .

  3. 结论:VIP、TXB2可能为反映卫分证病理的微观指标及肺卫失宣的物质基础。

    Conclusion : VIP and TXB2 might be the microcosmic indexes which can reflect the pathology of Weifen syndrome , and they might be material foundations of sluggishness of lung-wei .

  4. 结论:VIP可能为反映卫分证实质的客观实验指标及肺卫失宣的物质基础,且与病位无关;

    Conclusion : VIP may be an index reflecting the pathology of weifen syndrome , and it is one of the material foundations of sluggishness of lung-defensive qi , but it has nothing to do with the infected internal organs .

  5. 结果:1.急性白血病卫分证阶段、气分证阶段、营分证阶段IL-1β、IL-6、TNF-α呈连续上升,各组间差异显著,且与健康对照组有显著差异性。

    The serum levels of IL - β , IL-6 and TNF-a keep rising in the stage of Weifen syndrome of Acute Leukemia , Qifen syndrome and Yingfen syndrome , and among with there are significant differences , what 's more the 3 stages differentiate from the well-bing group much .

  6. 为卫分证、气分证和热入营血,邪在卫气治宜疏风清热透邪解毒;

    Dispersing wind , clearing away heat and toxic substances , expelling pathogenic factors are applicable to pathogen involving Weifen and Qifen .

  7. 【目的】观察薄氏腹针疗法治疗急性病毒性上呼吸道感染发热中医辨证属卫分证、气同病证的临床疗效,探讨外感发热卫分证、卫气同病证证候与疗效间的关系。

    Objective : To observe the clinic therapeutic effect that abdominal needle therapy treat the people with weifen syndrome and syndrome involving the defense and qi phase , and to discuss the relationship between syndrome and clinic therapeutic effect .

  8. 中医为主治疗卫、气分证传染性非典型肺炎的理论探讨和临床研究自主呼吸试验在慢性阻塞性肺病患者撤离人工气道中的作用

    Theoretical Exploration and Clinical Research of Treating Severe Acute Respiratory Syndrome with Traditional Chinese Medicine Therapy ; The effect of spontaneous breathing trial in extubation in chronic obstructive pulmonary disease patients